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(57) ABSTRACT 
A method for the manufacture of a photosensitizing nanoma 
terial (40) and the products thereof are disclosed. The method 
for the treatment of a biological target (50) is disclosed. The 
photosensitizing nanomaterial (40) comprises a metal com 
plex tetrapyrrole derivative (10). The metal complex tetrapy 
rrole derivative (10) is attached by an axial covalent bond (60) 
to the surface (25) of a solid nanomaterial (20). The solid 
nanomaterial (20) has at least one dimension in the nanometer 
and/ or the micrometer range. 
10 Claims, 10 Drawing Sheets 
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MANUFACTURE AND PRODUCTS THEREOF 
OF PHOTOSENSITIZING NANOMATERIALS 
AND THEIR USE IN PHOTODYNAMIC 
TREATMENT 
PRIORITY CLAIM AND CROSS-REFERENCE 
TO RELATED APPLICATIONS 
This application claims the bene?t of priority under 35 
U.S.C. §119 and any other United States or other laW of the 
following: UK (GroBbritannien) patent application No. GB 
08 1 9978 .8 ?led on 31 Oct. 2008, Which is incorporated herein 
by reference in its entirety for all purposes. 
BACKGROUND 
1. Technical Field 
The present invention relates to a method for the manufac 
ture of photosensitiZing nanomaterials and products thereof 
and the use of the photosensitiZing nanomaterials in photo 
dynamic treatment to inactivate a biological target. 
2. Background Art 
The manufacture of a photosensitiZing metal complex 
bound to a nanomaterial is knoWn in the art. 
Japanese Patent Publication Number JP-A-2007/196104, 
Which is titled “Zeolite material including complex and its 
utilisation”, is assigned to The Nayoga Institute of Japan. The 
J P-A-2007/ 196104 disclosure teaches a Zeolite solid support 
including a complex containing a metal of groups 1-13 of the 
periodic table and an oxygen activation metal complex 
included in a unit cell of the Zeolite solid support and a 
photosensitizing metal complex retained (preferably 
included in the unit cell of the Zeolite solid support) on the 
Zeolite solid support. The metal contained in the Zeolite solid 
support is for example, at least one of silver, copper, Zinc, 
platinum and palladium. The oxygen activation metal com 
plex is for example, a metal phthalocyanine complex synthe 
sised in the unit cell of the Zeolite solid support. 
The ’104 disclosure does not teach the attachment of a 
Si(IV) tetrapyrrole metal complex that is covalently bonded 
directly to the surface of a solid support. The ’104 disclosure 
fails to teach the use of silica nanoparticles as the nanomate 
rial. There is no disclosure pertaining to the use of the manu 
factured products for the photodynamic treatment of biologi 
cal targets. 
Japanese Patent Publication Number JP-A-62-104807 is 
titled “Macromolecular metal complex” and the applicant is 
Shirai Hiroyashi of Nippon Carbide Kogyo KK, Nittesu KK, 
Earth Clean KK. The ’807 disclosure teaches a metal complex 
With a high odour-decomposition rate and With outstanding 
persistency When used as a deodorant. The metal complex is 
manufactured by bonding a macromolecular compound to a 
metal phthalocyanine derivative to form an oxidative and 
reductive metal complex. The macromolecular metal com 
plex can be obtained by bonding to a macromolecular com 
pound (e.g., polystyrene, poly-vinyl alcohol) a metal phtha 
locyanine derivative containing peripheral substituents, 
Where the central atom M is an oxidative or reductive metal 
atom (M can be manganese, cobalt, nickel or iron, the sub 
stituents can be carbonyl chloride or acetaldehyde). The 
metal complex is used by dissolution or dispersion in Water or 
an organic liquid, or by adsorption to a Zeolite solid support. 
The ’807 disclosure does not teach the attachment of a 
Si(IV) tetrapyrrole metal complex covalently bonded directly 
to the surface of a Zeolite L nanomaterial. The ’807 disclosure 
fails to teach the use of silica nanoparticles as the nanomate 
rial. There is no disclosure in this ’807 document pertaining to 
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the use of the manufactured product for the photodynamic 
treatment for biological targets. 
Japanese Patent Publication Number JP-A-2007-231247 is 
titled “Method for producing phthalocyanine compound pig 
ment micro-particle, phthalocyanine compound pigment 
micro-particle obtained by the same, ink-jet ink for colour 
?lter, colouring photosensitive resin composition and photo 
sensitive resin transfer material comprising the same and 
colour ?lter, liquid crystal display device and CCD device 
using the same”. The applicant of this ’247 disclosure is Fuji 
Film Corp. The ’247 disclosure discloses a method for pro 
ducing a phthalocyanine compound pigment of micro-par 
ticles of nanometer siZe, the micro-particles having excellent 
dispersion stability and ?uidity and achieving high contrast 
and Weather resistance, to provide an inkjet ink for a colour 
?lter, a colouring photosensitive resin composition and a 
photosensitive resin transfer material comprising the same 
and to provide the colour ?lter, a liquid crystal display device 
and a CCD device (charge coupled device) using the same. 
The method for producing the phthalocyanine compound 
pigment micro-particle is achieved as folloWs. A pigment 
solution is prepared by dissolving a phthalocyanine com 
pound pigment in a good solvent and mixing With a solvent 
compatible With the good solvent and providing a poor sol 
vent for the pigment to deposit and produce the pigment and 
thus prepare a dispersion of the pigment micro-particle of 
nanometer siZe. In the process, a high polymer having a 
mass-average molecular Weight 21,000 is contained in the 
dispersion of the pigment micro-particle. 
This ’247 disclosure teaches pigment micro-particles 
Which consist of phthalocyanine Which is not covalently 
attached to a nanomaterial. The ’247 disclosure does not 
teach the use of the active pigment micro-particles for the 
photodynamic treatment of biological targets. 
One article in the academic journal, Eur. J. Inorg. Chem., 
2008, 2975 is titled “Synthesis and photo physical properties 
of silica-gel supported photo functional (phthalocyaninato) 
silicon complexes”, describes the synthesis and photo physi 
cal properties of the silica-gel supported photosensitiZing 
phthalocyaninato silicon complex (SiPc-SiO2). The photo 
physical properties and surface structures of the silica-gel 
supported photosensitiZing phthalocyaninato) silicon com 
plex (SiPc-SiO2) Were investigated in terms of their elec 
tronic absorption, ?uorescence, singlet (102) oxygen lumi 
nescence, and nitrogen adsorption-desorption isotherms. The 
nitrogen adsorption-desorption isotherms indicate that the 
planes of SiPcs anchored by axial ligands are parallel to the 
silica gel surface. In the proposed structure the tetradentate 
phthalocyaninato (Pc) ligands are considered to coordinate 
With the silica-gel particles, since the central elements of the 
SiPcs, such as Si4OiSi4OH, are similar to constituents of 
the silica-gel. The intensities of ?uorescence and singlet oxy 
gen luminescence decrease With an increase in the amount of 
SiPcs due to interactions betWeen the SiPcs aggregates. By 
changing the amount of SiPcs, solid materials are prepared 
based on Pc complexes With both monomeric photo physical 
properties and a high ability for singlet oxygen generation. 
The electronic absorption spectrum of the photosensitive (ph 
thalocyaninato) silicon complex (SiPc-SiO2) indicate that a 
Wide optical WindoW is maintained betWeen the Soret and Q 
absorption bands, even at high concentrations of SiPcs i.e. 
[SiPc]z10_2 M. This results in deep green solids, Which is 
unlike the blue colour of the crystals or concentrated solutions 
(>10‘5 M) of SiPc(OH)2. 
The Eur. J. Inorg. Chem. disclosure does not teach the 
attachment of a Si(IV) tetrapyrrole metal complex With a 
covalent bond to the surface of a Zeolite L nanomaterial. The 
US 8,193,343 B2 
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Eur. J. Inorg. Chem. disclosure also fails to teach the use of 
silica nanoparticles as the nanomaterial. There is no disclo 
sure in the Eur. J. Inorg. Chem. publication pertaining to the 
use of the photosensitiZing phthalocyaninato silicon complex 
(SiPc-SiO2) in photodynamic therapy. 
BACKGROUND OF INVENTION 
PhotosensitiZers are chemical substances that can be used 
for the photodynamic treatment of a biological target to kill 
living organisms such as bacteria. PhotosensitiZers are 
chemical substances Which produce toxic species When 
exposed to light. Tetrapyrrole metal complexes and metal 
complex tetrapyrrole derivatives are an example of a photo 
sensitiZer. Tetrapyrrole metal complexes have been found to 
be useful substances for the photodynamic treatment of can 
cer. An advantage of the tetrapyrrole metal complex as pho 
tosensitiZers arises due to their loW toxicity and high e?i 
ciency for the photo-induced inactivation of the biological 
target. PhotosensitiZers based on the tetrapyrrole metal com 
plex play an important role in modern technology and have 
applications in many technical ?elds. Tetrapyrrole metal 
complexes and metal complex tetrapyrrole derivatives have 
been studied as dyes and pigments, but they are also useful 
chromophores. Tetrapyrrole metal complexes and metal com 
plex tetrapyrrole derivatives have applications in light emit 
ting diodes (LEDs), optical limiting devices, molecular elec 
tronics, non-linear optical devices, liquid crystals, gas 
sensors, chemical catalysts, semiconducting materials, pho 
tovoltaic cells, and in electro-chromic displays see for 
example C. A. Strassert, et al., Photochem. Photobiol. Sci. 7 
(2008) 1234]. 
There is currently a great deal of interest in soluble metal 
complex tetrapyrrole derivatives. The interest in soluble 
metal complex tetrapyrrole derivatives is due to their unique 
electrical, optical and catalytic properties. These properties of 
the metal complex tetrapyrrole derivatives are negatively 
affected by a tendency of the metal complex tetrapyrrole 
derivatives to form aggregates. The aggregation is caused by 
J's-stacking of the conjugated, planar, macrocyclic structure of 
the aromatic moieties of the metal complex tetrapyrrole 
derivatives. The tendency toWards aggregation leads to a 
reduction in the solubility of the metal complex tetrapyrrole 
derivatives and consequently limits their use in a number of 
applications Where a degree of solubility and/or a degree of 
monomerisation of the metal complex tetrapyrrole deriva 
tives Would be favourable. Furthermore, the utilisation of the 
metal complex tetrapyrrole derivatives for biomedical appli 
cations, such as photodynamic treatment requires that the 
metal complex tetrapyrrole derivatives is effectively dis 
solved or dispersed in an aqueous medium or in another 
biocompatible solvent. A further requirement for the use of 
metal complex tetrapyrrole derivatives in biomedical appli 
cations is that the metal complex tetrapyrrole derivative is 
preferably in a monomeric form, this is because dimers and 
higher aggregates of the metal complex tetrapyrrole deriva 
tives are inactive inbiological applications see for example C. 
A. Strassert, et al., Photochem. Photobiol. Sci. 7 (2008) 1234. 
Photodynamic treatment has been used for the treatment of 
cancer and other diseases. Photodynamic treatment has 
received regulatory approval in many countries. Photody 
namic treatment of cancer is based on the observation that 
certain non-toxic photosensitiZers accumulate in malignant 
cancerous cells. One of the best knoWn examples of a non 
toxic photosensitiZer is a derivative of hematoporphyrin 
knoWn as Photofrin see for example A. JuZeniene, et al., 
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Photochem. Photobiol. Sci. 6 (2007) 1234 and M Hamblin, et 
al., Photochem. Photobiol. Sci. 3 (2004) 436. 
Photodynamic treatment involves irradiating a photosen 
sitiZer With light of an appropriate Wavelength to excite the 
photosensitiZer to an excited singlet state. The excited singlet 
state may then undergo intersystem crossing to a slightly 
loWer energy, but to a longer lived triplet state species. The 
photosensitiZer may then react further via one or both of tWo 
possible pathWays knoWn as Type I and Type 11 photo pro 
cesses. The Type I and the Type 11 photo processes require the 
presence of O2. The Type 1 photo process involves electron 
transfer reactions from the photosensitiZer’ s triplet state With 
the participation of a substrate to produce radical ions. The 
radical ions can then react With the O2 to produce a cytotoxic 
species, such as a superoxide, and/or a hydroxyl and a lipid 
radical. The Type 11 photo process involves energy transfer 
from the photosensitiZer’s triplet state to the ground triplet 
state of molecular oxygen (302), to produce excited state 
singlet oxygen (102). The 1O2 species has the ability to oxi 
dise a Wide variety of biological targets, such as proteins, 
nucleic acids and lipids. The oxidation of the biological target 
leads to cytotoxicity Within the biological to photo induced 
inactivate the biological target as a result of the photodynamic 
treatment; see for example A. JuZeniene, et al., Photochem. 
Photobiol. Sci. 6 (2007) 1234 and M Hamblin, et al., Photo 
chem. Photobiol. Sci. 3 (2004) 436. 
The use of photodynamic treatment has certain advantages 
over other therapies. One advantage is that photodynamic 
treatment is dually selective. The photosensitiZer can be 
delivered to a speci?c site of the biological target, such as a 
tumour or a pathogen; and the light used in the photodynamic 
treatment can be accurately pointed to the affected site of the 
biological target; see for example A. JuZeniene, et al., Photo 
chem. Photobiol. Sci. 6 (2007) 1234 and M Hamblin, et al., 
Photochem. Photobiol. Sci. 3 (2004) 436. 
Although initially developed as a therapy for the treatment 
of cancer, the most successful application of photodynamic 
treatment (With FDA approval) has been in the ?eld of oph 
thalmology for the treatment of age-related macular degen 
eration. Other photodynamic treatments include, the treat 
ment of psoriasis, arthritis, Barretts’ oesophagus and 
atherosclerosis and restenosis in veins and in arteries target 
see for example A. JuZeniene, et al., Photochem. Photobiol. 
Sci. 6 (2007) 1234. 
Most of the photosensitiZers used for the photodynamic 
treatment of cancer and other tissue diseases are based on the 
metal complex tetrapyrrole derivative. Examples of metal 
complex tetrapyrrole derivative include, porphyrins (HPD), 
chlorins (BPD, SnEt2, m-THPC), bacteriochlorins 
(TOOKAD), phthalocyanines (Pc4) and texaphyrins (Lutex). 
The use of the tetrapyrrole metal complex in photodynamic 
treatment is due to the loW toxicity toWards living cells in the 
absence of photo-irradiation; see for exampleA. JuZeniene, et 
al., Photochem. Photobiol. Sci. 6 (2007) 1234 and M Hamb 
lin, et al., Photochem. Photobiol. Sci. 3 (2004) 436. 
Chemical substances With a different molecular frameWork 
have been used as photosensitiZers. These different molecular 
frameworks include halogenated xanthenes such as Rose 
Bengal, phenothiaZines such as toluidine blue O and methyl 
ene blue, and acridines or perylenequinones, such as hyperi 
cin see for example M Hamblin, et al., Photochem. Photobiol. 
Sci. 3 (2004) 436. 
The tendency toWards aggregation and the lack of solubil 
ity and selectivity limit the use of the metal complex tetrapy 
rrole derivative as a suitable photosensitiZer. The uncon 
trolled diffusion of the metal complex tetrapyrrole derivative 
to unaffected tissues in the vicinity of the biological target 
US 8,l93,343 B2 
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cannot be avoided. Up to noW, soluble multifunctional metal 
complex tetrapyrrole derivatives With selectivity towards bio 
logical targets and imaging capabilities have not been 
described. Such soluble multifunctional metal complex tet 
rapyrrole derivative Would therefore be highly desirable see 
for example A. JuZeniene, et al., Photochem. Photobiol. Sci. 
6 (2007) 1234. 
A covalent bond betWeen the metal complex tetrapyrrole 
derivative and a solid nanomaterial provides a photosensitiZ 
ing nanomaterial With the ability to prevent the problems 
associated With aggregation of the metal complex tetrapyrrole 
derivative. 
By manipulating and ?ne-tuning the siZe of the solid nano 
material, the tendency of the metal complex tetrapyrrole 
derivative, to diffuse into adjacent tissues of the biological 
target can be reduced. This reduction in the tendency of 
uncontrolled diffusion of the metal complex tetrapyrrole 
derivative into adjacent tissues of the biological target 
increases the selectivity of the photosensitiZing nanomaterial 
When used in the photodynamic treatment of the biological 
target. 
The solid nanomaterial can be Zeolite nanocrystals or 
silica-based nanoparticles and can be nanoparticles that con 
tain silicon, gold, silver, and metal oxides Where the metal of 
the metal oxide can be iron, tin, titanium, aluminium or com 
binations thereof. The nanoparticles can be a core-shell nano 
particles With free coordinating groups (such as hydroxyl, 
thiol, amino, carboxylate, phosphate), or any coordinating or 
chelating group or combinations thereof on the solid nano 
material surface. These coordinating or chelating groups can 
be used to form a covalent bond With a variety of molecules. 
The solid nanomaterial provides a solid support for the attach 
ment of the metal complex tetrapyrrole derivative. In addi 
tion, highly luminescent molecules can be entrapped into the 
cavities and/or defects of the solid nanomaterial, for example 
into the channels of the Zeolite L crystals (see G. CalZaferri, et 
al., AngeW. Chem. Int. Ed. 42 (2003) 3732) or in a matrix of 
the silica nanoparticles (see I. L. Chavez, et al., Langmuir 24 
(2008) 2064). The use the solid nanomaterial provides the 
possibility for the manufacture of multifunctional arrays of 
photosensitiZing nanomaterials With photosensitiZing and 
imaging properties. 
Furthermore functionalisation of the solid nanomaterial 
surface With targeting groups, eg amino, oligopeptide or 
antibody moieties, can lead to the effective and ef?cient 
attachment of the photosensitiZing nanomaterial to a speci?c 
biological target. This enables more e?icient photodynamic 
treatment of the biological target With the photosensitiZing 
nanomaterial. This functionalisation of the nanomaterial sur 
face increases the selectivity of the photosensitiZing nanoma 
terial When used in the photodynamic treatment of biological 
targets. 
SUMMARY OF THE INVENTION 
The present application discloses a method for the manu 
facture of a photosensitiZing material and products thereof. 
The photosensitiZing material is used for the treatment of a 
biological target. The photosensitiZing material has a metal 
complex tetrapyrrole derivative that is covalently bonded to 
the surface of a solid material. The present application also 
discloses the use of the photosensitiZing material for the 
photo induced inactivation of the biological target by using 
photodynamic treatment. 
The metal complex tetrapyrrole derivative is attached to the 
surface of the solid material by covalent bonds. The surface of 
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the solid material provides an e?icient and effective substrate 
for the manufacture of the photosensitiZing material With 
minor synthetic effort. 
The solid material can be Zeolite nanocrystals and can be 
nanoparticles. The nanoparticles can be silicon based nano 
particles and metal oxide nanoparticles. The solid material 
has at least one dimension in the nanometer and/ or the 
micrometer range. 
The metal complex tetrapyrrole derivative may be a Si(IV) 
phthalocyanine metal complex and derivates thereof. 
The biological target can be a virus, a eukaryotic or a 
prokaryotic cell such as the bacterium E. Coli. 
The solid material avoids problems associated With aggre 
gation of metal complex tetrapyrrole derivative. 
In general, any application Where the monomeric form of 
the metal complex tetrapyrrole derivative is required can be 
implemented by the present disclosure. 
Photo physical and photo biological investigations of the 
manufactured photosensitiZing material described by the 
present application provide results Which shoW the mono 
meric binding of the metal complex tetrapyrrole derivative to 
the solid material. 
The photosensitiZing material possesses the ability to pro 
duce singlet oxygen molecules. The photosensitiZing mate 
rial has been used for the photodynamic treatment of the 
biological target E. Coli. The photosensitiZing material has 
been used for the photodynamic treatment of the biological 
target Neisseria Gonorrhoeae. 
In an aspect of the present disclosure, a liquid such as Water 
can be decontaminated by photodynamic treatment by using 
the photosensitiZing material provided by the present disclo 
sure. 
Very little toxicity in the absence of irradiation (i.e., dark 
toxicity) When using the photosensitiZing material for the 
photodynamic treatment of the biological target is achieved 
since the solid material and the metal complex tetrapyrrole 
derivative of the photosensitiZing material are biocompatible. 
Therefore the photosensitiZing materials can be used for in 
vitro and/or in vivo photodynamic treatment of infections, 
cancers or other diseases in any conceivable pharmaceutical 
formulation. 
In a further aspect of the present disclosure, the methodol 
ogy is extended to materials With luminescent dopants 
entrapped into matrices, defects, cavities or channels of the 
solid material. The channels of Zeolite L crystals of the can be 
loaded With a highly luminescent molecule such as DXP. The 
luminescent materials give rise to the photosensitiZing mate 
rial having both imaging and photosensitiZing properties. 
In a further aspect of the present disclosure, the surface of 
the photo sensitiZing material can be functionalised With func 
tional groups. The functional groups provide a means for the 
photosensitiZing material to have an enhanced af?nity to be 
attracted to a speci?c biological target. This enhanced a?inity 
increases the selectivity of the photosensitiZing material for 
the biological target. The functionalisation of the surface of 
the photosensitiZing material With amino groups can increase 
the dispersion ability of the photosensitiZing material in an 
aqueous medium and can also facilitate the attachment of the 
photosensitiZing material to a cell surface, thus increasing the 
selectivity of the photosensitiZing material, as Well as the 
effectiveness for the photo inactivation of the biological tar 
get. 
The multifunctional properties of the photosensitiZing 
materials are desirable for the simultaneous photodynamic 
treatment of the biological target and for the labelling of cells 
and viruses. Furthermore, the photodynamic treatment With 
the photosensitiZing material provides a targeted and selec 
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tive treatment means, thus avoiding the uncontrolled diffu 
sion of the metal complex tetrapyrrole derivative into the 
environment and/ or neighbouring tissue. 
DESCRIPTION OF FIGURES 
FIG. 1 shoWs a schematic for the manufacture of a photo 
sensitiZing nanomaterial in an example of the present disclo 
sure. 
FIG. 2 shoWs an image of aggregated crystals of metal 
complex tetrapyrrole derivative (in this case Si(IV) phthalo 
cyanine chloride) Which are unable to emit red light (left), in 
contrast With the highly emissive monomeric metal complex 
tetrapyrrole derivative bound to the surface of a solid nano 
material (in this case Zeolite L) (right). The emission observed 
is attributed to the monomeric form of the metal complex 
tetrapyrrole derivative on the Zeolite L surface. 
FIG. 3 shoWs the characteristic phosphorescence of singlet 
oxygen molecules, Which can only be produced in the pres 
ence of the monomeric form of the metal complex tetrapyr 
role derivative (in this example Si(IV) phthalocyanine chlo 
ride) bound to the surface of the solid nanomaterial (in this 
case Zeolite L) according to an example of the present disclo 
sure. The spectrum Was recorded from a suspension of the 
photosensitiZing nanomaterial in CD2Cl2 at room tempera 
ture, kexf670 nm. 
FIG. 4 shoWs a) schematic for the manufacture of the 
photosensitiZing nanomaterial With silica nanoparticles as the 
solid nanomaterial and Si(IV) phthalocyanine chloride as the 
metal complex tetrapyrrole derivative. b)A SEM image of the 
obtained photosensitiZing nanomaterial With silica nanopar 
ticle as the solid nanomaterial and Si(IV) phthalocyanine 
chloride as the, according to an example of the present dis 
closure. 
FIG. 5 shoWs the a) excitation (kem:674 nm) and b) emis 
sion (X85610 nm) spectra of the photosensitiZing nanomate 
rial, With silica nanoparticle as the solid nanomaterial and 
Si(IV) phthalocyanine chloride as the metal complex tetrapy 
rrole derivative, according to an aspect of the present disclo 
sure, in CD2Cl2 at room temperature. The emission observed 
is attributed to the monomeric form of the metal complex 
tetrapyrrole derivative on the nanoparticle surface. 
FIG. 6a shoWs an overlay of confocal ?uorescence and 
bright ?eld microscopy images of labeled E. coli bacteria. 
The rod-like shaped cells are labeled by a green emitting 
photosensitiZing nanomaterial (kexf488 nm). FIG. 6b shoWs 
a scanning electron microscopy image of an E. coli cell cov 
ered With the photosensitiZing nanomaterial. 
FIG. 7 shoWs a schematic of the photodynamic treatment 
process, Which induces photo inactivation of biological tar 
gets by irradiating the photosensitiZing nanomaterial With 
light. 
FIG. 8 shoWs the results of experiments using the photo 
sensitiZing nanomaterial in the photodynamic treatment of 
the biological target E. Coli. 
a) Utilisation of the photosensitiZing nanomaterials With Zeo 
lite L as the solid nanomaterial and Si(IV) phthalocyanine 
chloride as the metal complex tetrapyrrole derivative, 
according to an aspect of the present disclosure. Percentage 
of dead biological target With progressing irradiation time 
is shoWn; White bars represent the data for Zeolite L crys 
tals, black bars represent data for photosensitiZing nano 
materials Without irradiation, striped bars represent data 
for irradiated photosensitiZing nanomaterials. 
b) Utilisation of the photosensitiZing nanomaterials With 
silica nanoparticles as the solid nanomaterial and Si(IV) 
phthalocyanine chloride as the metal complex tetrapyrrole 
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derivative, according to an aspect of the present disclosure. 
Percentage of dead biological target With progressing irra 
diation time is shoWn; White bars represent the data for 
silica nanoparticles, black bars represent data for the pho 
tosensitiZing nanomaterials Without illumination, striped 
bars represent data for irradiated photosensitiZing nanoma 
terials. 
c) As in a), the differences being the 80 times smaller siZe of 
the Zeolite L crystals used as the solid nanomaterial, tetra 
t-butyl-substituted Si(IV) phthalocyanine hydroxide used 
as the metal complex tetrapyrrole derivative, and an amino 
coating of the photosensitiZing nanomaterial. The gray 
columns represent non-functionalised Zeolite L crystals 
Without irradiation. 
FIG. 9 shoWs tWo ?uorescence images of the photosensi 
tiZing nanomaterial With Zeolite L crystals as the solid nano 
material (in this case doped With the green emitting dye DXP 
and the surface modi?ed With amino groups), and tetra-t 
butyl-substituted Si(IV) phthalocyanine hydroxide as the 
metal complex tetrapyrrole derivative. On the left side, the 
green luminescence upon selective excitation of DXP is 
shoWn. On the right side, the red luminescence upon selective 
excitation of the tetra-t-butyl-substituted Si(IV) phthalocya 
nine hydroxide is shoWn. 
FIG. 10 shoWs a confocal ?uorescence image of E. Coli 
cells labelled With the photosensitiZing nanomaterial With 
Zeolite L crystals as the solid nanomaterial (in this example 
doped With the green emitting dye DXP and surface modi?ed 
With amino groups), and tetra-t-butyl-substituted Si(IV) 
phthalocyanine hydroxide as the metal complex tetrapyrrole 
derivative. This shoWs that doping With ?uorescent dyes and 
surface modi?cation With amino groups provides a labelling 
tool for the biological target, to Which the photosensitiZing 
nanomaterial Will shoW a greater af?nity. 
DETAILED DESCRIPTION 
For a complete understanding of the present disclosure and 
the advantages thereof, reference is made to the folloWing 
detailed description taken in conjunction With the accompa 
nying ?gures. 
It should be appreciated that the various aspects of the 
present disclosure discussed herein are merely illustrative of 
the speci?c Ways to make and use the technology and do not 
limit the scope of technology When taken into consideration 
With the claims and the folloWing detailed description and the 
accompanying ?gures. It should be observed that features 
from one aspect of the disclosure can be combined With 
features from other aspects of the disclosure. 
The teachings of the cited documents should be incorpo 
rated by reference into the description. 
Photodynamic treatment provides a means for the treat 
ment of a biological target 50 by the photo-induced inactiva 
tion of the biological target 50 (such as prokaryotic and 
eukaryotic cells and viruses) and for the treatment of cancer 
and other diseases. A source of light excites a photosensitiZ 
ing nanomaterial 40 Which in turn generates highly reactive 
singlet oxygen (102) from non-reactive triplet oxygen mol 
ecules (302), see for exampleA. JuZeniene, et al., Photochem. 
Photobiol. Sci. 6 (2007) 1234 and M Hamblin, et al., Photo 
chem. Photobiol. Sci. 3 (2004) 436. 
Since the highly reactive singlet oxygen (102) also dam 
ages neighbouring unaffected (healthy) tissue near the bio 
logical target 50, an optical ?bre is usually used for treatments 
involving in vivo photodynamic treatment. The optical ?bre is 
used to ensure that irradiation of the biological target 50 of the 
affected tissue occurs and to prevent irradiation of the unaf 
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fected tissue near the biological target 50. The metal complex 
tetrapyrrole derivative 10 (When not bound to a stationary 
nanomaterial) diffuses through the entire body of a patient 
under photodynamic treatment. Therefore many Weeks after 
this photodynamic treatment, a patient is required to avoid 
exposure to intense sources of photo irradiation (i.e. light and 
sun), see for example A. JuZeniene, et al., Photochem. Pho 
tobiol. Sci. 6 (2007) 1234 and M Hamblin, et al., Photochem. 
Photobiol. Sci. 3 (2004) 436. 
The highly e?icient production of the singlet oxygen 102 
can be achieved by the use of the metal complex tetrapyrrole 
derivative 10. The metal complex tetrapyrrole derivative 10 
can convert up to 70% of absorbed light (red photons) into the 
singlet oxygen 102, see for example C. A. Strassert, et al., 
Photochem. Photobiol. Sci. 7 (2008) 1234. 
The functionalisation of the metal complex tetrapyrrole 
derivative 10 With appropriate axial orperipheral substituents 
can further shift the absorption/emission of the metal com 
plex tetrapyrrole derivative 10 to the desired near infrared 
region (700 nm-900 nm). The near infrared region (700 
nm-900 nm) is the optimal therapeutic region for photody 
namic treatment involving in vivo applications. Examples of 
the axial or peripheral substituents include, but are not limited 
to, amino, hydroxyl, chloro, alkyl, alkoxy, sulfanyl, siloxy or 
aryl groups, see for example C. A. Strassert, et al., Photo 
chem. Photobiol. Sci. 7 (2008) 1234. 
The present application teaches a method for the manufac 
ture and products thereof of a photosensitiZing nanomaterial 
40. The present application also teaches the use of the pho 
tosensitiZing nanomaterial 40 for the photodynamic treat 
ment of the biological target 50. The metal complex tetrapy 
rrole derivative 10 is attached to the solid nanomaterial 20 by 
the covalent bond 60. The covalent bond 60 is made betWeen 
the nanomaterial surface 25 of the solid nanomaterial 20 and 
the metal of the metal complex tetrapyrrole derivative 10. 
The making of a covalent bond 60 betWeen the metal com 
plex tetrapyrrole derivative 10 and a solid nanomaterial 20 
overcomes at least some of the problems associated With 
diffusion of the metal complex tetrapyrrole derivative 10 into 
the neighbouring tissue of a biological target 50. This happens 
because by means of a covalent bond 60 betWeen a stationary 
solid nanomaterial 20 and the metal core, the metal complex 
tetrapyrrole derivative 10 is not free to diffuse aWay from the 
biological target 50, i.e., to diffuse through the body of the 
patient under photodynamic treatment. The covalent bond 60 
is very stable and is an irreversible bond betWeen the metal 
complex tetrapyrrole derivative 10 and a nanomaterial sur 
face 25 of the solid nanomaterial 20. 
The presence of the covalent bond 60 Within the photosen 
sitiZing nanomaterial 40 overcomes at least some of the prob 
lems associated With aggregation and diffusion of the metal 
complex tetrapyrrole derivative 10 as the metal complex tet 
rapyrrole derivative 10 is bound monomerically to the nano 
material surface 25. 
The axial covalent bond 60 ensures that the metal complex 
tetrapyrrole derivative 10 is attached onto the nanomaterial 
surface 25 of the solid nanomaterial 20. 
The metal complex tetrapyrrole derivative 10 can be one of 
a Si(IV) phthalocyanine complex or a derivative thereof, With 
any peripheral substituent, such as tert-butyl groups. 
The metal complex tetrapyrrole derivative 10 can be a 
metal complex of a porphyrin, a benZo porphyrin, a phthalo 
cyanine, a napthalocyanine or any derivatives thereof. 
The metal complex tetrapyrrole derivative 10 can have 
axial reactive groups, such as chloride or hydroxide. The axial 
groups of the metal complex tetrapyrrole derivative 10 react 
With the anchoring groups present on the nanomaterial sur 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
10 
face 25, during the reaction the covalent bond 60 is formed 
betWeen the metal of the metal complex tetrapyrrole deriva 
tive 10 and the nanomaterial surface 25. 
In a further aspect of the present disclosure, the metal 
complex tetrapyrrole derivative 10 can include derivatives of 
the metal complex tetrapyrrole derivative 10, With for 
example, peripheral tert-butyl groups (FIGS. 9, 10), axial 
chloride (FIGS. 1, 2, 3, 4, 5) or hydroxide groups (FIGS. 9, 
10). 
The solid nanomaterials 20 can include, but is not limited 
to, Zeolite nanocrystals and/or a silicon-based nanoparticle. 
The nanoparticles can also comprise silicon, gold, silver, and 
metal oxides Where the metal of the metal oxide can be iron, 
tin, titanium, aluminium or combinations thereof. The nano 
particles can include core-shell nanoparticles Which have for 
example a core of iron or gold and a silica shell. The nano 
particles can also have ferromagnetic properties. The solid 
nanomaterial can have coordinating groups (such as 
hydroxyl, thiol, amino, carboxylate, phosphate), or any coor 
dinating or chelating group or combinations thereof on the 
solid nanomaterial surface 25. These coordinating or chelat 
ing groups can be used to form a covalent bond With a variety 
of molecules. The solid nanomaterial 20 can be a Zeolite L 
crystal or silica nanoparticles. The solid nanomaterial 20 can 
also be a mixture of solid nanomaterials 20. 
The solid nanomaterial 20 is non-toxic to the biological 
target 50. This non-toxicity of the solid nanomaterial 20 
makes it useful for the in vivo photodynamic treatment of the 
biological target 50. 
The solid nanomaterial 20 and the metal complex tetrapy 
rrole derivative 10 are non toxic to biological targets 50. The 
covalent bond 60 betWeen the solid nanomaterial 20 and the 
metal complex tetrapyrrole derivative 10 overcomes prob 
lems associated With diffusion of the metal complex tetrapy 
rrole derivative 10 to nearby (healthy) biological tissue of the 
biological target 50. 
FIG. 1 illustrates an example of the method for the manu 
facture of the photosensitiZing nanomaterial 40. In this 
example the metal complex tetrapyrrole derivative 10 is a 
Si(IV) phthalocyanine chloride complex. The solid nanoma 
terial 20 is provided by Zeolite L crystals. The nanomaterial 
surface 25 is the surface of the solid nanomaterial 20. As 
noted above, the solid nanomaterial 20 can be, but is not 
limited to, Zeolite L crystals or silica nanoparticles, or a 
mixture of both. 
FIG. 2 shoWs the transmission and ?uorescent microscope 
images of a suspension of the photosensitiZing nanomaterial 
40. In this example of the present disclosure, the photosensi 
tiZing nanomaterials 40 consists of silicon (IV) phthalocya 
nine chloride as the metal complex tetrapyrrole derivative 10 
bound to a Zeolite L crystal as the solid nanomaterial 20. In 
this example it is shoWn that the crystals of the silicon (IV) 
phthalocyanine chloride complex are aggregates. These 
aggregates do not exhibit emission. When the silicon (IV) 
phthalocyanine chloride complex is covalently attached to the 
nanomaterial surface 25 of the Zeolite L crystals as a mono 
mer, the metal complex tetrapyrrole derivative 10 shoWs a 
strong luminescence. 
We refer noW to FIG. 3, Which shoWs the characteristic 
phosphorescence of singlet oxygen 102. The singlet oxygen 
102 is produced by reaction of triplet oxygen (302) With the 
monomeric form of the silicon (IV) phthalocyanine chloride 
complex, Which is present on the surface of the Zeolite L 
crystals, according to an example of the present disclosure. 
The generation of the singlet oxygen 102 Was investigated by 
measuring the near IR emission spectrum of the photosensi 
tiZing nanomaterials 40 in a suspension With deuteriated 
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dichloromethane as the solvent (CD2Cl2). FIG. 3 shows the 
characteristic phosphorescence spectrum from the singlet 
oxygen 102 produced by the silicon (IV) phthalocyanine 
chloride bound to the nanomaterial surface 25 of the Zeolite L 
crystal. The results demonstrate the ability of the photosen 
sitiZing nanomaterial 40 to photo-produce singlet oxygen 
(102). Furthermore, the characteristic emission of the singlet 
oxygen (102) can be quenched With a singlet oxygen 
quencher, such as DABCO (diaZabicyclooctane), Which rein 
forces that the manufactured photosensitiZing nanomaterial 
40 is able to generate singlet oxygen. The investigation of a 
solution of the pure metal complex tetrapyrrole derivative 10 
(in this aspect silicon (IV) phthalocyanine chloride) in the 
same solvent (CDZClZ), but not bound to a nanomaterial 
surface 25 of the solid nanomaterial 20, does not shoW any 
generation of the singlet oxygen (102). No characteristic 
phosphorescence can be detected. 
FIG. 4a shoWs another aspect of the present disclosure for 
the manufacture of the photosensitiZing nanomaterials 40. In 
this aspect of the disclosure, the solid nanomaterial 20 is silica 
nanoparticles and the metal complex tetrapyrrole derivative 
10 is provided by a Si(IV) phthalocyanine chloride complex. 
In FIG. 4a, the photosensitiZing nanomaterial 40 has a 
SiiOiSi (siloxane) axial covalent bond 60. The siloxane 
axial covalent bond 60 is formed betWeen the metal (silicon 
atom) of the metal complex tetrapyrrole derivative 10, and an 
oxygen atom of a terminal hydroxyl group present on the 
nanomaterial surface 25 and silicon atoms present on the 
nanomaterial surface 25 of the solid nanomaterial 20. 
FIG. 4b shoWs the SEM images of the photosensitiZing 
nanomaterials 40 comprising of the metal complex tetrapyr 
role derivative 10 (in this example, silicon (IV) phthalocya 
nine chloride) bound to the nanomaterial surface 25 of the of 
the solid nanomaterial 20 (in this example, silica nanopar 
ticles). FIG. 4b demonstrates that the structure of the solid 
nanomaterial 20 remains unaffected after the attachment of 
the metal complex tetrapyrrole derivative 10. This re?ects the 
stability of the photosensitiZing nanomaterials 40. 
FIG. 5 shoWs a) excitation (kem:674 nm) and b) emission 
(kex:6l0 nm) spectra of the photosensitiZing nanomaterials 
40 of the metal complex tetrapyrrole derivative 10 (in this 
example, silicon (IV) phthalocyanine chloride) bound to the 
nanomaterial surface 25 of the solid nanomaterial 20 (in this 
example, silica nanoparticles), in CD2Cl2 suspension at room 
temperature. Such an emission spectra can only be attributed 
to the monomeric form of the metal complex tetrapyrrole 
derivative 10 (in this example, silicon (IV) phthalocyanine 
chloride), Which is covalently attached to the nanomaterial 
surface 25 of the solid nanomaterial 20 as a monomer. 
FIG. 6a shoWs an overlay of confocal ?uorescence and 
bright ?eld microscopy images of labeled E. coli bacteria. 
The rod-like shaped cells are labeled by a green emitting 
photosensitiZing nanomaterial (kexf488 nm). FIG. 6b shoWs 
a scanning electron microscopy image of an E. coli cell cov 
ered With the photosensitiZing nanomaterial. 
A further aspect of the present disclosure is shoWn in FIG. 
7. FIG. 7 shoWs a scheme of the photodynamic treatment 
process used to photo inactivate the biological target 50 by 
irradiation of the photosensitiZing nanomaterials 40 With 
light. In this aspect the photosensitiZing nanomaterial 40 is 
irradiated With light to generate the singlet oxygen 102 by 
energy transfer from the metal complex tetrapyrrole deriva 
tive 10 to the triplet oxygen 302. The singlet oxygen 102 has 
the ability to damage the biological target 50. Examples of the 
implementation of the photosensitiZing nanomaterials 40 for 
the photodynamic treatment of a biological target 50 include, 
but are not limited to, the photodynamic decontamination of 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
12 
Water. In an example of the present disclosure the photosen 
sitiZing nanomaterial 40 has been used for the treatment of the 
biological target 50 E. Coli. The biological target 50 can also 
be for example Neisseria Gonorrhoeae or even a bacterial 
cell that is resistant to treatment by an antibiotic. 
FIG. 8 shoWs the results of experiments using the photo 
sensitiZing nanomaterial 40 for the photodynamic treatment 
of the biological target 50 E. Coli. In these examples of the 
present disclosure, the biological target 50 E. Coli is present 
as a suspension in Water. a) Utilization of photosensitiZing 
nanomaterials 40 With Zeolite L crystals as the solid nanoma 
terial 20 and Si(IV) phthalocyanine chloride as the metal 
complex tetrapyrrole derivative 10, according to an aspect of 
the present disclosure. A percentage of dead biological targets 
With progressing irradiation time is shoWn; White bars repre 
sent the data for Zeolite L crystals, black bars represent data 
for photosensitiZing nanomaterials 40 Without illumination, 
striped bars represent data for irradiated photosensitiZing 
nanomaterials 40. b) Utilisation of photosensitiZing nanoma 
terials 40 With silica nanoparticles as the solid nanomaterial 
20 and Si(IV) phthalocyanine chloride as the metal complex 
tetrapyrrole derivative 10, according to an aspect of the 
present disclosure. The percentage of dead biological targets 
With progressing irradiation time is shoWn; White bars repre 
sent the data for the solid nanoparticles 10, black bars repre 
sent data for the photosensitiZing nanomaterials 40 Without 
illumination, striped bars represent data for irradiated photo 
sensitiZing nanomaterials 40. c) The same as in a), the differ 
ence being the 80 times smaller siZe of the Zeolite L crystals 
used as the solid nanomaterial 20, the tetra-t-butyl-sub stituted 
Si(IV) phthalocyanine hydroxide used as the metal complex 
tetrapyrrole derivative 10, and the amino coating of the pho 
tosensitiZing nanomaterial 40. The grey columns represent 
non-functionalised Zeolite L crystals Without illumination. 
These results demonstrate the photodynamic effect, exempli 
fying that the irradiation of the photosensitiZing nanomateri 
als With light results in signi?cant cell-death of the biological 
target 50. It is observed that by decreasing the siZe of the 
Zeolite L crystals and the surface modi?cation With amino 
groups, increases the ef?ciency of the photodynamic treat 
ment used to photo inactivate the biological target 50 of E. 
Coli. 
It Was surprising that the photosensitiZing nanomaterial 40 
also exhibits biocompatibility and a lack of toxicity to the 
biological target 50. The concurrent irradiation and function 
alisation of the solid nanomaterial 20 With the metal complex 
tetrapyrrole derivative 10 causes signi?cant inactivation of 
the biological target 50. 
FIG. 9 shoWs tWo ?uorescence images of the photosensi 
tiZing nanomaterial With Zeolite L nanocrystals as the solid 
nanomaterial 20 (in this case doped With the green emitting 
dye DXP and the nanomaterial surface 25 modi?ed With 
amino groups), and tetra-t-butyl-substituted Si(IV) phthalo 
cyanine hydroxide as the metal complex tetrapyrrole deriva 
tive 10. On the left, the green luminescence upon selective 
excitation of DXP is shoWn. On the right, the red lumines 
cence upon selective excitation of the Si(IV) phthalocyanine 
is shoWn. These results demonstrate the effective functionali 
sation of the solid nanomaterial 20 With both DXP and the 
monomeric metal complex tetrapyrrole derivative 10. 
FIG. 10 shoWs a confocal ?uorescence image of the bio 
logical target 50iE. Coli cells Which have been labelled With 
the photosensitiZing nanomaterial 40. The photosensitiZing 
nanomaterial 40 is this example consists of Zeolite L crystals 
as the solid nanomaterial 20 (in this case doped With the green 
emitting dye DXP and the nanomaterial surface 25 modi?ed 
With amino groups), and tetra-t-butyl-substituted Si(IV) 
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phthalocyanine hydroxide as the metal complex tetrapyrrole 
derivative 10. FIG. 10 demonstrates that doping the photo 
sensitiZing nanomaterial 40 With ?uorescent dyes and surface 
amino modi?cation provides an effective labelling tool for 
the biological target 50. The amino functionalisation 
enhances the adherence of the photosensitiZing nanomaterial 
40 to the biological target 50, Which increases the labelling 
capability of the photosensitiZing nanomaterial 40. 
The manufacture of the photosensitiZing nanomaterial 40 
is conducted in the dark and under an inert atmosphere as 
folloWs: a suspension of the solid nanomaterial 20 is saturated 
With the metal complex tetrapyrrole derivative 10 in an anhy 
drous aromatic solvent such as toluene or 1-chloro-naphtha 
lene. The suspension is then continuously stirred and continu 
ously heated for a period of betWeen 3 to 24 hours. During the 
heating and stirring of the suspension the photosensitiZing 
nanomaterial 40 is manufactured in the suspension. Once the 
photosensitiZing nanomaterial 40 is manufactured, it is ?l 
tered from the suspension and Washed by pouring fresh 
amounts of the same anhydrous aromatic solvent that Was 
used in the manufacture step over the manufactured photo 
sensitiZing nanomaterial 40. The photosensitiZing nanomate 
rial 40 is then dried prior to use. 
In an aspect of the present disclosure the inert atmosphere 
is provided by an inert gas such as nitrogen or argon. In a 
further aspect of the present disclosure the anhydrous organic 
solvent used for the manufacture is the same anhydrous 
organic solvent used to Wash the manufactured photosensi 
tiZing nanomaterial 40. 
EXAMPLES 
Zeolite L crystalsi50 nm long Zeolite L crystals Were 
purchased from Clariant. 
4 pm long Zeolite L crystals Were manufactured according 
to the procedure described by A. Z. Ruiz, et al., Monatsh. 
Chem. 136 (2005) 77. 
Silica nanoparticles. The silica nanoparticles Were manu 
factured by folloWing the procedure described by L. M. LiZ 
MarZan, et al., J. Phys. Chem. B 107 (2003) 7312. 
Example 1 
Manufacture of Solid Nanomaterial 20 Loaded With 
DXP Dye 
The Zeolite L crystals Were exchanged With potassium ions 
prior to being loaded With the DXP dye. The DXP dye (N,N' 
Bis(2,6-dimethylphenyl)perylene-3,4,9,10-tetracarboxylic 
diimide) Was purchased from Aldrich and used Without fur 
ther puri?cation. The DXP dye Was inserted into the 50 nm 
long Zeolite L crystals from the gas phase by folloWing the 
procedure described by G. CalZaferri, et al., AngeW. Chem. 
Int. Ed. 42 (2003) 3732. 
Example 2 
Manufacture of PhotosensitiZing Nanomaterial 40 
1 mg of the metal complex tetrapyrrole derivative 10, 5 mg 
anhydrous tetra-tert-butyl Si(IV) phthalocyanine dihydrox 
ide, purchased from Sigma-Aldrich and used as provided, 
Was added to a toluene suspension containing the DXP 
loaded Zeolite L solid nanomaterial 20 (as described in 
example 1) and sonicated for 45 minutes. The resultant mix 
ture Was sonicated for 10 minutes and then heated at 1100 C. 
for 3 hours. 
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The manufactured photosensitiZing nanomaterial 40 Was 
Washed With anhydrous toluene, until no metal complex tet 
rapyrrole derivative 10, anhydrous tetra-tert-butyl Si(IV) 
phthalocyanine dihydroxide, could be detected in the super 
natant liquid. 
In an alternative aspect the resultant mixture comprising 
the manufactured photosensitiZing nanomaterial 40 Was cen 
trifuged to separate the manufactured photosensitiZing nano 
material 40. The manufactured photosensitiZing nanomate 
rial 40 Was Washed by suspending the manufactured 
photosensitiZing nanomaterial 40 in anhydrous toluene, 
Water/Genapol (from Clariant and used as received) and 
Water until no anhydrous tetra-tert-butyl Si(IV) phthalocya 
nine dihydroxide, could be detected in the supernatant liquid. 
Example 3 
Functionalisation of PhotosensitiZing Nanomaterial 
40 With Amino Groups 
The photosensitiZing nanomaterial 40 (as described in 
Example 2) comprising the DXP dye and the metal complex 
tetrapyrrole derivative 10, anhydrous tetra-ter‘t-butyl Si(IV) 
phthalocyanine dihydroxide Was functionalised on the sur 
face of the photosensitiZing nanomaterial 40 With amino 
groups by folloWing the procedure described by Z. Popovic, 
et al. AngeW. Chem. Int. Ed. 46 (2007) 6188. 
The crystals of the photosensitiZing nanomaterial 40 Were 
dried at 600 C. and stored in the dark. 
Example 4 
Manufacture of PhotosensitiZing Nanomaterial 40 
1 mg of dry metal complex tetrapyrrole derivative 10 
Si(IV) phthalocyanine dichloride, purchased from Sigma 
Aldrich and used as provided, Was added to a suspension of 
l-chloro-naphthalene containing the solid nanomaterial 20, 4 
pm long Zeolite L crystals. The resultant mixture Was soni 
cated for 10 minutes and then heated at 1100 C. for 3 hours. 
The manufactured photosensitiZing nanomaterial 40 Was 
Washed With anhydrous 1-chloronaphthalene, until no metal 
complex tetrapyrrole derivative 10 Si(IV) phthalocyanine 
dichloride, could be detected in the supernatant liquid. 
The crystals of the photosensitiZing nanomaterial 40 Were 
dried at 600 C. and stored in the dark. 
Example 5 
Manufacture of PhotosensitiZing Nanomaterial 40 
1 mg of dry metal complex tetrapyrrole derivative 10 
Si(IV) phthalocyanine dichloride purchased from Sigma-Al 
drich and used as provided, Was added to a suspension of 
l-chloro-naphthalene containing the solid nanomaterial 20, 
silica nanoparticles. The resultant mixture Was sonicated for 
10 minutes and then heated at 1100 C. for 3 hours. The 
manufactured photosensitiZing nanomaterial 40 Was Washed 
With anhydrous 1-chloro-naphthalene, until no metal com 
plex tetrapyrrole derivative 10 Si(IV) phthalocyanine dichlo 
ride could be detected in the supernatant liquid. 
The crystals of the photosensitiZing nanomaterial 40 Were 
dried at 600 C. and stored in the dark. 
Example 6 
Biological Target SOiE. Coli 
The bacteria samples of the biological target 50, of E. Coli 
strain BL21 (DE3) pLys Were taken from an incubated stock 
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solution in Lysogeny broth (LB) medium and Were re-sus 
pended in a phosphate buffered saline (PBS, pH 7.4) solution. 
The concentration of bacteria in solution Was estimated by 
optical density. 
Example 7 
Biological Target 50iNeisseria Gonorrhoeae 
The bacteria samples of the biological target 50, of Neis 
seria Gonorrhoeae strain N400 (recA inducible) Was main 
tained on agar containing NaCl (5 g L“, Roth), KZHPO4 (4 g 
L_l, Roth), KHZPO4 (l g L_l, Roth), Proteose Peptone No. 3 
(15 g L_l, BD), Starch (0.5 g L_l, SigmaAldrich), lsoVitaleX 
Enrichment (10 mL L_1, BD) and Were groWn overnight at 
37° C. and 5% C02. The Neisseria Gonorrhoeae N400 cells 
Were re-suspended in supplemented medium With PBS (pH 
7.4), L-glutamine (2 mM, lnvitrogen), sodium pyruvate (8 
mM, lnvitrogen), HEPES (30 mM, Roth) and D-glucose (11 
mM, Roth). The concentration of bacteria cells in solution 
Was estimated by optical density. 
Example 8 
E. Coli Labelled by PhotosensitiZing Nanomaterial 
40 
1 mg of the photosensitiZing nanomaterial 40 loaded With 
DXP dye (as described in example 3) Was suspended in 1 mL 
PBS (lx, pH:7.4), and sonicated for 1 hour. The solution of E. 
Coli in PBS (lx, pH 7.4), With a concentration of approxi 
mately 108 cell mL'l, and the suspension containing the 
photosensitiZing nanomaterial 40, Were mixed in equal vol 
umes in a cuvette. The mixture Was then placed in a cuvette 
holder equipped With a magnetic stirrer. After 30 minutes an 
aliquot of the suspension Was taken and analysed in the ?uo 
rescence microscope in order to see the E. Coli bacteria 
labelled With the green ?uorescence provided by the DXP 
dye. 
Example 9 
Photodynamic Treatment of E. Coli 
1 mg of photosensitiZing nanomaterial 40 (any of the ones 
previously described in example 3, example 4 and example 5) 
Was suspended in 1 mL PBS (lx, pH:7.4), and sonicated for 
1 hour. The solution of E. Coli in PBS (pH 7.4), With a 
concentration of approximately 108 cell mL_1, and the sus 
pension containing the photosensitiZing nanomaterial 40, 
Were mixed in equal volumes in a cuvette. The mixture Was 
then placed in a cuvette-holder equipped With a magnetic 
stirrer and irradiated using a tungsten lamp (irradiance at the 
cuvette of 3 mW cm_2). An aperture and a cut-off ?lter 
(}\,>570 nm) Were used together With a Water ?lter, in order to 
cut-off the blue and the infrared part of the irradiation beam, 
respectively. Every 30 minutes aliquots of 6.2 uL Were taken 
and propidium iodide Was added to reach a ?nal concentration 
of 48 uM. The samples Were alloWed to stain in the dark for 15 
minutes before analysis on the ?uorescence microscope, 
Where pictures Were recorded under bright ?eld illumination 
and under excitation at 500-600 nm. For each picture the total 
number of bacteria Was counted With the aid of a counting 
chamber, and compared to the number of Pl-stained bacteria. 
Control experiments Without illumination and Without phtha 
locyanine functionalisation Were performed using analogous 
methodology as described. 
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Example 10 
Photodynamic Treatment of Neisseria Gonorrhoeae 
1 mg of photosensitiZing nanomaterial 40 Was suspended 
in 500 pL PBS (pH:7.4) supplemented With L-glutamine, 
sodium pyruvate, HEPES and D-glucose and sonicated for 
betWeen 30 and 60 minutes. A solution of Neisseria Gonor 
rhoeae, With a concentration of approximately 108 cell mL_1, 
and the suspension containing the photosensitiZing nanoma 
terial 40, Were mixed in equal volumes in a cuvette. The 
mixture Was then placed in a cuvette-holder equipped With a 
magnetic stirrer and irradiated using a tungsten lamp (irradi 
ance at the cuvette of 3 mW cm_2). An aperture and a cut-off 
?lter (7»>570 nm) Were used together With a Water ?lter, in 
order to cut-off the infrared part of the irradiation beam, 
respectively. Every 30 minutes aliquots Were taken and pro 
pidium iodide Was added to reach a ?nal concentration of 48 
uM. The samples Were alloWed to stain in the dark for 15 
minutes before analysis on the ?uorescence microscope, 
Where pictures Were recorded under bright ?eld illumination 
and under excitation at 500-600 nm. For each picture the total 
number of bacteria Was counted With the aid of a counting 
chamber, and compared to the number of Pl-stained bacteria. 
Control experiments Without illumination and Without phtha 
locyanine functionalisation Were performed using analogous 
methodology as described. 
Fluorescence emission and excitation spectra of the pho 
tosensitiZing nanomaterial 40 suspended in CH2Cl2 Were 
recorded by using a HORIBA J obin-Yvon IBH FL-322 Fluo 
rolog 3 spectrometer. The phosphorescence spectrum of 1O2 
in CD2Cl2 Was recorded by using a HORIBA Jobin-Yvon 
IBH FL-322 Fluorolog 3 spectrometer equipped With an air 
cooled Hamamatsu H9l70-75 (lnP/lnGaAs) PMT detector. 
Fluorescence microscopy Was carried out With an Olympus 
lX-7l equipped With a Hg high pressure lamp, air objective 
l00><l.0, an Olympus U-MNB2 excitation cube and a colour 
camera. The confocal microscopy images have been recorded 
utiliZing a Leica TCS SPE microscope, equipped With a 488 
nm diode laser using a scan rate of 400 MHZ. 
The scanning electron microscopy images have been 
recorded using a Zeiss 1540 EsB Dual Beam Focused Ion 
Beam/ Field Emission Scanning Electron Microscope (SEM) 
With a Working distance of 8 mm and an electronic high 
tension (EHT) of 3 kV. 
Having thus described the present technology in detail, it is 
to be understood that the foregoing detailed description of the 
technology is not intended to limit the scope ofthe technology 
thereof. What is desired to be protected by letters patent is set 
forth in the folloWing claims. 
List of Reference Numerals 
10 Metal complex tetrapyrrole derivative 
20 Solid nanomaterial 
25 Nanomaterial surface 
30 Reaction conditions 
40 PhotosensitiZing nanomaterial 
50 Biological target 
60 Covalent bond 
The invention claimed is: 
1. A method for the manufacture of a photosensitiZing 
nanomaterial the method comprising: 
adding a solid material to an anhydrous aromatic solvent to 
form a suspension, 
saturating the suspension With a compound comprising 
metal complex tetrapyrrole, 
heating and stirring the suspension under an inert atmo 
sphere in the dark, 
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?ltering and Washing the manufactured photosensitiZing 
nanomaterial from the suspension; and 
drying the photosensitiZing nanomaterial. 
2. The method according to claim 1, Wherein the compound 5 
comprising the metal complex tetrapyrrole is selected from a 
group consisting of the metal complex tetrapyrrole compris 
ing one of a porphyrin, a benZo porphyrin, a phthalocyanine, 
a napthalocyanine or any derivatives thereof. 
3. The method according to claim 1, Wherein the solid 
material is selected from the group consisting of Zeolite L 
crystals, silica-based nanoparticles or metal oxides. 
4. The method according to claim 1, Wherein the solid 
material has ferromagnetic properties. 
18 
5. The method according to claim 1, Wherein the heating is 
at a temperature of betWeen 90° C. and 2200 C. 
6. The method according to claim 1, Wherein the aromatic 
organic solvent is selected from the group comprising of 
toluene or l-chloro-naphthalene. 
7. The method according to claim 1, Wherein the heating is 
for betWeen 2 hours and 24 hours. 
8. The method according to claim 1, Wherein the mixture is 
at least one of heated and agitated. 
9. The method according to claim 1, Wherein the solid 
material is loaded With a DXP dye. 
10. The method according to claim 1, Wherein the photo 
sensitiZing nanomaterial is functionalised With amino groups. 
* * * * * 
